Erlotinib vs Metformin

Erlotinib vs Metformin: Overview

This comparison examines the pharmacological differences between Erlotinib and Metformin.

Mechanism of Action

Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

Metformin: Activates AMP-activated protein kinase, decreasing hepatic glucose production.

Pharmacokinetics

Half-life: Erlotinib — 36 hours; Metformin — 4-9 hours.

Chemical Properties

Molecular Formula: Erlotinib — C22H23N3O4; Metformin — C4H11N5.

Molecular Weight: Erlotinib — 393.4380 g/mol; Metformin — 129.1640 g/mol.

Type: Erlotinib — Small molecule; Metformin — Small molecule.